glp/gip/glucagon & cagrilintide 8mg/2mg Medscape | Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is Cagrilintide + GLP-1 S (2+2mg)
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25












&srotate=0)










